Role of muscarinic receptors in the contraction of jejunal smooth muscle in the horse: An in vitro study.

The research investigates the role of different muscarinic receptor subtypes and the effects of their selective or nonselective antagonists in the contraction of horse’s jejunal smooth muscle.

Objective of the Study

• The main purpose of this study is to understand the role and effects of different muscarinic receptor (MR) subtypes within horse jejunal smooth muscle contraction. The authors aimed to see the impact of nonselective and selective M1, M2 and M3 MR antagonists on these contractions. The ultimate goal is to provide insights that could improve the efficacy and safety of treatments involving selective antimuscarinic drugs in horses.

Methodology

• The study was carried out using segments of circular muscles taken from equine jejunum. These were then placed into organ baths and connected to isotonic transducers to observe any changes.
• The researchers then analysed the effects on the ACh concentration-response curves, and electrical field stimulation (EFS)-evoked contractions of the intestinal preparations. Changes were induced by the nonselective or selective MR antagonists compared to pre-drug levels.

Results

• The nonselective MR antagonist (Atropine), and selective M1 (pirenzepine) and M3 (p-FHHSiD) antagonists all demonstrated competitive antagonism towards ACh.
• The selective M2 antagonist (Methoctramine), showed antagonism towards ACh in a concentration-unrelated fashion, but displayed competitive antagonism in response to carbachol, a nonselective muscarinic agonist.
• Atropine was observed to dose-dependently reduce EFS-evoked contractions, with a maximum reducing effect of -45.64±6.54%. Furthermore, when neurokinin receptors were blocked, the atropine-insensitive contractions were almost completely abolished.
• The M3 antagonist (p-FHHSiD) dose-dependently reduced EFS-induced contractions, whilst the M1 antagonist (pirenzepine) only caused a minor decrease. Interestingly, the M2 antagonist (Methoctramine) enhanced contractions at high concentrations, but this increase was abolished when neurokinin receptors were blocked.

Conclusions

• The study concludes that the cholinergic contractions in horse jejunum are primarily mediated by M3 receptors. M2 selective antagonists seem to have a minuscule effect on cholinergic contractions and appear to enhance neurokininergic contractions of the equine jejunum.
• The study also suggests that the use of selective M2 antagonists may pose a lower risk of causing intestinal hypomotility compared to using nonselective drugs.